Maximum Dose of Mycophenolate Mofetil
The maximum recommended dose of mycophenolate mofetil is 3 grams per day (1.5 g twice daily), which is FDA-approved for cardiac and hepatic transplant recipients. 1
FDA-Approved Maximum Dosing by Indication
The FDA label clearly delineates maximum doses based on transplant type:
Renal transplantation: 2 g/day (1 g twice daily) is the standard dose. While 3 g/day was studied and proven safe, no efficacy advantage was demonstrated, and the 2 g/day dose showed a better overall safety profile 1
Cardiac transplantation: 3 g/day (1.5 g twice daily) 1
Hepatic transplantation: 3 g/day (1.5 g twice daily) 1
Pediatric patients (3 months to 18 years): 600 mg/m² twice daily, up to a maximum of 2 g/day (1 g twice daily) for oral suspension. For patients with body surface area >1.5 m², dosing is 1 g twice daily (2 g/day maximum) 1, 2
Context-Specific Dosing
Lupus Nephritis
For maintenance therapy in lupus nephritis, the KDIGO 2024 guidelines recommend:
- Mycophenolate mofetil: 750-1000 mg twice daily (1.5-2 g/day)
- Mycophenolic acid: 540-720 mg twice daily 3
These are maintenance doses, not maximum doses, and are lower than transplant dosing.
Dose Adjustments and Safety Limits
Critical caveat: In renal transplant patients with severe chronic renal impairment (GFR <25 mL/min/1.73 m²) outside the immediate post-transplant period, doses greater than 1 g twice daily (2 g/day) should be avoided 1. This represents an important safety ceiling in this population.
If neutropenia develops (ANC <1.3 × 10³/µL), dosing should be interrupted or reduced regardless of the indication 1.
Clinical Considerations
The FDA label explicitly states that no dose adjustments are recommended for patients with severe hepatic parenchymal disease in renal transplant recipients, though data are limited for cardiac transplant patients with severe hepatic disease 1.
Important administration note: Mycophenolate mofetil should be administered on an empty stomach for optimal absorption, as food decreases peak concentration (Cmax) by 40%, though it does not affect overall exposure (AUC) 1.